DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Contribución de congreso (ConferenceOutput)
P22-44 Estrogenic activity of nanoplastics in vitro
The large-scale production of plastic items, their endurance, and inadequate recycling practices have led to massive plastic pollution. [1] Degradation of larger plastic items through mechanical, biological, or chemical processes can lead to the formation of nanoplastics, particles characterized by small size and large surface area. Due to those properties, nanoplastics can penetrate different biological barriers, posing potential risk for different organisms. Humans are continuously exposed to plastics through multiple environmental and consumer-related pathways, while the consequences for human health are still being investigated. [2] Since the endocrine system regulates many biological functions and plays a key role in the development of many diseases, it is crucial to examine the effect of nanoplastics on its function.
This study investigates toxicity and endocrine disrupting potential of 8 different plastic nanoparticles (PNPs) and their mixtures using cell line HeLa-9903, designed to assess the effects of various chemicals on the estrogen receptor (ER) activity. To explore the influence of polymer type and nanoparticle size on their ability to interact with ER, we used 4 different polymers and 5 different sizes. Polystyrene nanoparticles (PSNPs, 50 nm, 150 nm, 350 nm), polyethylene nanoparticles (PENPs, 50 nm, 350 nm), polypropylene nanoparticles (PPNPs, 50 nm, 180 nm) and polyethylene terephthalate nanoparticles (PETNPs, 80 nm) were included in this research. Four different PNPs mixtures were evaluated: MIX50 (PSNPs 50 nm, PENPs 50 nm, PPNPs 50 nm and PET), MIX150 (PSNPs 150 nm and PPNPs 180 nm), MIX350 (PSNPs 350 nm and PENPs 350 nm) and MIXPS (PSNPs 50 nm, 150 nm and 350 nm). MTS assay was used to evaluate the cytotoxicity of PNPs individually and in mixtures, while only non-toxic combinations were tested for their interaction with ER, according to the OECD test guideline No. 455. [3] Results showed that PENPs (350 nm) and PPNPs (180 nm) individually act as ER agonists. The same effect was observed with all mixtures except the one with 3 differently sized PSNPs. As PSNPs did not exhibit agonistic activity regardless of their size, the findings of this study suggest that polymer type has a more significant influence on endocrine activity than nanoparticle size., This study was performed using the facilities and equipment funded as part of the European Regional Development Fund project KK.01.1.1.02.0007 and the European Union – Next Generation EU programme (contract document designation 643-02/23-01/00016) and financed within EU H2020 project “PHOENIX” funded under grant agreement no. 953110, Peer reviewed
Project:
EC / H2020 953110
View at: http://hdl.handle.net/10261/440014